(Q36055271)

English

Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

author name string

R Menéndez

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R Más

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

A M Amor

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R M González

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J C Fernández

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

I Rodeiro

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Zayas

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

S Jiménez

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

50

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

255-262

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Lipid peroxidation and its role in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

2 October 2017

Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

Statistical considerations for performing multiple tests in a single experiment. 5. Comparing two therapies with respect to several endpoints.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014982

11 July 2018

The oxidative modification of low-density lipoproteins by macrophages

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00250.X

21 January 2018

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hypercholesterolemia in NIDDM with policosanol

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro inhibition of low-density lipoprotein oxidation by a gemfibrozil metabolite

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol-lowering effects of policosanol in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of policosanol on in vitro and in vivo rat liver microsomal lipid peroxidation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative status of lipoproteins in coronary disease patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10971310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.2000.00250.X

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36055271&oldid=1617887010"